Last update:
Oncology news
New AI approach aims to predict radiation dose before therapy in advanced prostate cancer
A new machine-learning approach for prostate-specific membrane antigen (PSMA) treatment of metastatic castration-resistant prostate cancer (mCRPC) could estimate radiation dose to tumors and healthy organs before therapy ...
12 hours ago
0
2
Q&A: Researcher discusses early-onset breast cancer in East Africa
Most breast cancer patients in Uganda and Ethiopia are diagnosed too late, and many lack access to life-saving treatment. Tove Ekdahl Hjelm defends her thesis "Early-onset breast cancer in East Africa: genetics, tumor characteristics ...
17 hours ago
0
7
One inhibitor, opposite outcome: How a double-target effect could reshape ferroptosis therapies
Switching off an enzyme that plays an important role in sugar metabolism, glycolysis, would normally be expected to cause serious problems for cells. Surprisingly, the opposite is also true: Cells can become highly resistant ...
May 30, 2026
0
5
Teclistamab extends remission in relapsed myeloma, with 70% progression-free at 18 months
Patients with relapsed multiple myeloma treated with the immunotherapy teclistamab lived significantly longer and remained in remission far longer than those receiving standard therapies, according to results from a major ...
May 29, 2026
0
6
Celiac disease may raise risk of heart attack, stroke and early death
People with celiac disease and dermatitis herpetiformis have a slightly increased risk of cardiovascular disease, certain types of blood cancer, and premature death. This is shown by a large U.S. registry study led by researchers ...
May 29, 2026
0
8
How lifestyle can protect childhood cancer survivors
Healthy lifestyles can reduce the risk of cardiovascular disease and other complications in childhood cancer survivors. These are the findings of two new international studies.
May 29, 2026
0
3
Targeted drug outperforms chemotherapy for patients with hard-to-treat lung cancer
The targeted therapy sunvozertinib was more effective than standard platinum-based chemotherapy as a first-line treatment for patients with advanced non-small cell lung cancer (NSCLC) driven by EGFR exon 20 insertion mutations ...
May 29, 2026
0
5
Autoimmune disease linked to poor outcomes with myelodysplastic syndrome
Having a preexisting autoimmune disease is an independent risk factor for poor outcomes with myelodysplastic syndrome (MDS), according to a study published in the June issue of Clinical Immunology.
May 29, 2026
0
4
Study identifies protein that helps eye cancer spread to the liver
A study led by researchers at Moffitt Cancer Center helps explain why uveal melanoma, the most common form of eye cancer, often spreads to the liver. The uvea is the middle layer of the eye, including the iris.
May 29, 2026
0
3
AI-powered atlas reveals new insights into tertiary lymphoid structures as prognostic and response biomarkers in cancer
In a study published in Science, researchers from The University of Texas MD Anderson Cancer Center have developed a spatial atlas of specialized immune structures, called tertiary lymphoid structures (TLSs), across multiple ...
May 28, 2026
0
7
Scientists identify metabolic target to overcome chemotherapy resistance in ovarian cancer
Many cancers can be treated by administering DNA-damaging agents, such as platinum-based chemotherapy, because the resulting DNA damage causes the cancer cells to die. A subset of cancers, however, including ovarian cancers, ...
May 28, 2026
0
7
Unexpected allies: Eosinophils may help predict cancer immunotherapy response and survival
Long regarded as cells involved primarily in allergic responses and antiparasitic defense, eosinophils are now drawing increasing attention in oncology. A review article led by Marie Gilon, an oncology resident physician ...
May 28, 2026
0
3
Veterans with cancer face years of elevated suicide risk, with danger highest just after diagnosis
Veterans diagnosed with cancer face a higher risk of suicide attempts—especially in the months following diagnosis—and that risk can persist for years, found a large, national study led by Oregon Health & Science University ...
May 28, 2026
0
3
Common anemia medication shows unexpected potential in cancer treatment
Common medications used to treat anemia may also slow down cancer cell growth, according to new research from Finland. Researchers from the University of Oulu and the University of Eastern Finland discovered that these drugs ...
May 28, 2026
0
6
A new AI model enables more efficient analysis of colorectal cancer samples
Researchers at the Faculty of Information Technology at the University of Jyväskylä have used artificial intelligence to speed up the analysis of colorectal cancer samples and predict the functioning of the cells' DNA repair ...
May 28, 2026
0
4
Lung cancer patients who smoke and don't quit before surgery still have positive outcomes, says study
Researchers at the University of Cincinnati College of Medicine have found that patients who continue to smoke ahead of lung cancer surgery have a higher risk of pulmonary complications, but their short-term mortality rate ...
May 28, 2026
0
3
Researchers identify new target to prevent aggressive form of prostate cancer
Researchers at Columbia University Irving Medical Center have identified a gene that drives the development of neuroendocrine prostate cancer (NEPC), an aggressive form of the disease. The study published in the Journal of ...
May 28, 2026
0
4
Obesity may influence how breast cancer spreads
Obesity may change how early-stage breast cancer becomes invasive, according to a study by University of Oklahoma researchers published in The American Journal of Pathology.
May 28, 2026
0
2
Healthy lifestyle shown to lower risk of death after cancer diagnosis
New evidence shows that sticking to five lifestyle recommendations improves survival after a later cancer diagnosis. The findings provide encouraging evidence that simple, achievable habits established before a cancer diagnosis ...
May 28, 2026
0
3
Breast tumors use sugar coating to evade immunity, opening potential immunotherapy path
Immunotherapies such as so-called checkpoint inhibitors activate the body's own immune system to fight cancer cells and have revolutionized the treatment of many types of tumor. In breast cancer, however, these therapies ...
May 27, 2026
0
20
Years after polyp removal, gut microbiome changes may still shape colorectal cancer risk
More than a decade after removal of an adenoma—a precancerous mass—from the colon, alterations to the gut microbiome and metabolites remain and may drive heightened risk of colorectal cancer (CRC), according to a study led ...
May 27, 2026
0
13
Naturally occurring molecule may help outsmart melanoma
Melanoma is one of the deadliest forms of skin cancer, due in large part to its ability to rapidly develop resistance to treatment. Now, researchers at the University of California San Diego have identified a naturally occurring ...
May 27, 2026
0
6
Lung cancer cells can revert identity to a branching state, fueling resistance and aggressive growth
Oncologists have discovered that lung cancer cells can change their identity to resist treatment. Research published in Molecular Oncology reveals how lung cancer cells can become more aggressive and harder to treat by reactivating ...
May 27, 2026
0
3
Simple blood test could lead to personalized lung cancer treatment
A single blood test could help doctors predict how lung cancer patients will respond to treatment before therapy begins, researchers have found. University of Queensland-led research focused on non-small cell lung cancer ...
May 27, 2026
0
4
Worse cancer mortality seen in association with exposure to coal operations
Occupational exposure and residential exposure to coal operations are associated with worse cancer mortality, according to a review published in Public Health.
May 27, 2026
0
5
